Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

lifescivc.com

LifeSciVC

Get the latest updates from LifeSciVC directly as they happen.

Follow now 34 followers

Latest posts

Last updated 3 days ago

The Plus-1 in “The Room Where It Happens”: A Survival Guide for Board Observers

3 days ago

By Julia Pian, Senior Associate at Atlas Venture, as part of the...

Two Roads Diverged

20 days ago

By Aimee Raleigh, Principal at Atlas Venture, as part of the From...

Biotech’s Most Effective Medicine: No FDA Approval Required

about 1 month ago

By Arthur Tzianabos, CEO of Lifordi Immunotherapeutics, as part of the From...

Patient-first, America-first: The Case For Global Collaboration

about 2 months ago

The rise of China in the global biopharma ecosystem has led to...

Year One as CEO: What Leadership Actually Feels Like

3 months ago

By Abbas Kazimi, CEO of Nimbus Therapeutics, as part of the From...

Stay Humble: Life Sciences as a Small Slice of an Increasingly Big Venture Pie

3 months ago

By Aimee Raleigh, Principal at Atlas Venture, as part of the From...

Do One Thing Every Day That Scares You

3 months ago

By Linda Bain, Venture Partner at Atlas Venture, as part of the...

How (and why) do you measure a year in the life? A Practical Guide to Defining Clinical Unmet Need

4 months ago

By Julia Pian, Senior Associate at Atlas Venture, as part of the...

Huntington’s Disease and The Triad of Therapeutic Conviction

4 months ago

By Eric Green, CEO of Trace Neuroscience, as part of the From...

Process-Driven Cadence: Biotech IPOs Demystified

4 months ago

An IPO remains one of the most sought-after brass rings on the...

Balancing the Risks and Rewards of Drug Development in China: A Small Biotech CEO Perspective

4 months ago

By Jonathan Montagu, CEO and founder of HotSpot Therapeutics, as part of...

Ex-US Clinical Trials: Tribulations, Preparations, and Expectations

4 months ago

By Arthur Tzianabos, CEO of Lifordi Immunotherapeutics, as part of the From...